Christof von Eiff

Prof. Dr. Christof von Eiff

orcid

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2002 in The Lancet Infectious Diseases
Verified
Journal Article
Closed access
CEChristof von Eiff
Christof von Eiff
GPGeorg Peters
Georg Peters
CHChristine Heilmann
Christine Heilmann

1 January 2005 in Drugs
Verified
Journal Article
Closed access
PDF file
CEChristof von Eiff
Christof von Eiff
BJBernd Jansen
Bernd Jansen
WKWolfgang Kohnen
Wolfgang Kohnen
Karsten BeckerKarsten Becker
Karsten Becker

1 June 2001 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
CEChristof von Eiff
Christof von Eiff
Karsten BeckerKarsten Becker
Karsten Becker
DMDieter Metze
Dieter Metze
GLGabriele Lubritz
Gabriele Lubritz
JHJohannes Hockmann
Johannes Hockmann
GPGeorg Peters
Georg Peters
Intracellular persistence assays were performed with small-colony variants (SCVs) derived from a patient with Darier's disease from whom different ph

1 May 2006 in Injury
Verified
Journal Article
Closed access
CEChristof von Eiff
Christof von Eiff
GPGeorg Peters
Georg Peters
Karsten BeckerKarsten Becker
Karsten Becker

1 July 2004 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Closed access
CEChristof von Eiff
Christof von Eiff
AFAlexander W Friedrich
Alexander W Friedrich
GPGeorg Peters
Georg Peters
Karsten BeckerKarsten Becker
Karsten Becker

15 January 2006 in Journal of Bacteriology
Verified
Journal Article
Open access
PDF file
CEChristof von Eiff
Christof von Eiff
PMPeter McNamara
Peter McNamara
Karsten BeckerKarsten Becker
Karsten Becker
DBDonna Bates
Donna Bates
XLXiang-He Lei
Xiang-He Lei
RPRichard A. Proctor
Richard A. Proctor
Standard biochemical tests have revealed that hemin and menadione auxotrophic Staphylococcus aureus small-colony variants (SCVs) exhibit multiple phenotypic changes. To provide a more complete analysis of the SCV phenotype, two genetically defined mutants with a stable SCV phenotype were comprehensively tested. These mutants, generated via mutations in menD or hemB that yielded menadione and hemin auxotrophs, were subjected to phenotype microarray (PM) analysis of over 1,500 phenotypes (including utilization of different carbon, nitrogen, phosphate, and sulfur sources; growth stimulation or inhibition by amino acids and other nutrients, osmolytes, and metabolic inhibitors; and susceptibility to antibiotics). Compared to parent strain COL, the hemB mutant was defective in utilization of a variety of carbon sources, including Krebs cycle intermediates and compounds that ultimately generate ATP via electron transport. The phenotype of the menD mutant was similar to that of the hemB mutant, but the defects in carbon metabolism were more pronounced than those seen with the hemB mutant. In both mutant strains, hexose phosphates and other carbohydrates that provide ATP in the absence of electron transport stimulated growth. Other phenotypes of SCV mutants, such as hypersensitivity to sodium selenite, sodium tellurite, and sodium nitrite, were also uncovered by the PM analysis. Key results of the PM analysis were confirmed in independent growth studies and by using Etest strips for susceptibility testing. PM technology is a new and efficient technology for assessing cellular phenotypes in S. aureus .